Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition

The Quick Take
The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China HANGZHOU, China, Nov. 3, 2026 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions company in Asia, announced the...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Drone Boat Maker Saildrone Wins Protest Over Navy Contract
A federal judge’s ruling on the side of the small defense contractor was a rarity, as most company protests against government bidding decisions do not prevail.
Business
Block raises full-year profit outlook as Cash App drives Q3 growth
Business
Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment
Earns ESG Risk Rating score of 9.0, ranking among the top 0.5% in the pharmaceuticals industry Advances from 'Low Risk' to 'Negligible Risk,' the lowest ESG…
Business
